← Back to headlines
Organon Stock Rises on Rumors of $12B Sun Pharma Buyout Deal
Organon's stock saw an increase following reports that Sun Pharma is close to a $12 billion buyout agreement for the company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
